应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
UNCY Unicycive Therapeutics, Inc.
已收盘 06-05 16:00:00 EDT
1.58
+0.19
+13.67%
盘后
1.60
+0.02
+1.27%
19:46 EDT
最高
1.60
最低
1.37
成交量
18.83万
今开
1.37
昨收
1.39
日振幅
16.55%
总市值
2,407万
流通市值
937.89万
总股本
1,523万
成交额
27.91万
换手率
3.17%
流通股本
593.60万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Unicycive Therapeutics Inc盘中异动 股价大涨6.09%报1.99美元
自选股智能写手 · 04-13
Unicycive Therapeutics Inc盘中异动 股价大涨6.09%报1.99美元
Unicycive Therapeutics(UNCY.US):2022年Q4财报实现营收0美元
证券之星 · 03-31
Unicycive Therapeutics(UNCY.US):2022年Q4财报实现营收0美元
Unicycive Therapeutics Inc股价上涨18.40% 市值涨536.52万美元
自选股智能写手 · 03-09
Unicycive Therapeutics Inc股价上涨18.40% 市值涨536.52万美元
Unicycive Therapeutics Inc股价拉升168.80% 市值涨3354.56万美元
自选股智能写手 · 03-06
Unicycive Therapeutics Inc股价拉升168.80% 市值涨3354.56万美元
Unicycive Therapeutics Inc盘中异动 早盘快速下挫5.36%报0.530美元
自选股智能写手 · 02-16
Unicycive Therapeutics Inc盘中异动 早盘快速下挫5.36%报0.530美元
加载更多
公司概况
公司名称:
Unicycive Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司一直处于休眠状态,直到2017年7月开始评估许可使用的多种药物。他们是一家生物技术公司,致力于为未满足的医疗条件开发治疗方法。当前,他们的两个计划针对有可能提供医疗收益的肾脏疾病。随着公司的发展和团队的建立,他们打算专注于确定肾脏疾病内外的医疗状况。他们目前的开发计划着重于两种新型疗法的开发:UNI 218或Renazorb(用于治疗慢性肾脏病患者的高磷酸盐血症)和UNI 494(用于治疗急性肾脏损伤)。
发行价格:
--
{"stockData":{"symbol":"UNCY","market":"US","secType":"STK","nameCN":"Unicycive Therapeutics, Inc.","latestPrice":1.58,"timestamp":1685995200000,"preClose":1.39,"halted":0,"volume":188293,"hourTrading":{"tag":"盘后","latestPrice":1.6,"preClose":1.58,"latestTime":"19:46 EDT","volume":3919,"amount":6121.383,"timestamp":1686008766361},"delay":0,"floatShares":5935993,"shares":15233836,"eps":-1.937806,"marketStatus":"已收盘","marketStatusCode":5,"change":0.19,"latestTime":"06-05 16:00:00 EDT","open":1.37,"high":1.6,"low":1.37,"amount":279103.889505,"amplitude":0.165468,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.937806,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1686038400000},"adr":0,"listingDate":1623988800000,"adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.4,"preClose":1.39,"latestTime":"09:29 EDT","volume":478,"amount":672.7157377999999,"timestamp":1685971770114},"postHourTrading":{"tag":"盘后","latestPrice":1.6,"preClose":1.58,"latestTime":"19:46 EDT","volume":3919,"amount":6121.383,"timestamp":1686008766361},"volumeRatio":3.294312},"requestUrl":"/m/hq/s/UNCY","defaultTab":"news","newsList":[{"id":"2327747130","title":"Unicycive Therapeutics Inc盘中异动 股价大涨6.09%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2327747130","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2327747130?lang=zh_CN&edition=full","pubTime":"2023-04-13 21:34","pubTimestamp":1681392881,"startTime":"0","endTime":"0","summary":"北京时间2023年04月13日21时34分,Unicycive Therapeutics Inc股票出现波动,股价急速拉升6.09%。截至发稿,该股报1.99美元/股,成交量1.0981万股,换手率0.07%,振幅3.96%。Unicycive Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.88%。Unicycive Therapeutics Inc公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。消息层面,截至21时34分,Unicycive Therapeutics Inc股票正面舆情新闻比例66.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230413213442835a4dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230413213442835a4dbc&s=b","is_publish_highlight":false},{"id":"2323564056","title":"Unicycive Therapeutics(UNCY.US):2022年Q4财报实现营收0美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2323564056","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2323564056?lang=zh_CN&edition=full","pubTime":"2023-03-31 22:12","pubTimestamp":1680271940,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics:2022年Q4财报实现营收0美元,前值为0美元;每股收益为-0.51美元,前值为-0.17美元,预期值为-0.24美元,比市场预期低112.50%。Unicycive Therapeutics公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。该公司的主导药物Renazorb是一种新型磷酸盐结合剂,正在开发用于治疗高磷血症。Unicycive的另一款药物UNI-494是一种新的化学实体,在晚期临床前开发中已获得物质成分专利保护,用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023033122153184211eea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023033122153184211eea&s=b","is_publish_highlight":false},{"id":"2318829914","title":"Unicycive Therapeutics Inc股价上涨18.40% 市值涨536.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2318829914","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2318829914?lang=zh_CN&edition=full","pubTime":"2023-03-09 22:30","pubTimestamp":1678372206,"startTime":"0","endTime":"0","summary":"北京时间2023年03月09日22时30分,Unicycive Therapeutics Inc股票出现异动,股价大幅拉升18.40%。Unicycive Therapeutics Inc股票所在的生物技术行业中,整体跌幅为2.00%。Unicycive Therapeutics Inc公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。消息层面,截至22时30分,Unicycive Therapeutics Inc股票正面舆情新闻比例40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303092230068061a5c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303092230068061a5c2&s=b","is_publish_highlight":false},{"id":"2317176460","title":"Unicycive Therapeutics Inc股价拉升168.80% 市值涨3354.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2317176460","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2317176460?lang=zh_CN&edition=full","pubTime":"2023-03-06 22:31","pubTimestamp":1678113084,"startTime":"0","endTime":"0","summary":"北京时间2023年03月06日22时31分,Unicycive Therapeutics Inc股票出现波动,股价大幅上涨168.80%。Unicycive Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Unicycive Therapeutics Inc、Bridgebio Pharma Inc、Oculis Holding Ag C/Wts 02/03/2028 涨幅较大,Unicycive Therapeutics Inc、Tcr2 Therapeutics Inc、Entera Bio Ltd较为活跃,换手率分别为171.23%、12.83%、8.49%,振幅较大的相关个股有Unicycive Therapeutics Inc、Adial Pharmaceuticals Inc、Armata Pharmaceuticals Inc,振幅分别为26.53%、21.43%、21.38%。Unicycive Therapeutics Inc公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303062231248266cc0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303062231248266cc0f&s=b","is_publish_highlight":false},{"id":"2311420174","title":"Unicycive Therapeutics Inc盘中异动 早盘快速下挫5.36%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2311420174","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2311420174?lang=zh_CN&edition=full","pubTime":"2023-02-16 23:40","pubTimestamp":1676562000,"startTime":"0","endTime":"0","summary":"北京时间2023年02月16日23时40分,Unicycive Therapeutics Inc股票出现异动,股价大幅跳水5.36%。Unicycive Therapeutics Inc股票所在的生物技术行业中,整体跌幅为1.14%。其相关个股中,Neximmune Inc、Ambrx Biopharma Inc、Sorrento Therapeutics Inc涨幅较大,Neximmune Inc、Ambrx Biopharma Inc、Inozyme Pharma Inc较为活跃,换手率分别为180.08%、81.00%、70.07%,振幅较大的相关个股有Ambrx Biopharma Inc、Neximmune Inc、Sorrento Therapeutics Inc,振幅分别为89.77%、42.95%、41.59%。Unicycive Therapeutics Inc公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230216234001825db44f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230216234001825db44f&s=b","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0296},{"period":"1month","weight":0.121},{"period":"3month","weight":1.8367},{"period":"6month","weight":0.9857},{"period":"1year","weight":0.5346},{"period":"ytd","weight":1.5741}],"websiteUrl":"http://www.unicycive.com","compareEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0488},{"period":"3month","weight":0.0587},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.0252},{"period":"ytd","weight":0.1189}],"name":"Unicycive Therapeutics, Inc.","description":"Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司一直处于休眠状态,直到2017年7月开始评估许可使用的多种药物。他们是一家生物技术公司,致力于为未满足的医疗条件开发治疗方法。当前,他们的两个计划针对有可能提供医疗收益的肾脏疾病。随着公司的发展和团队的建立,他们打算专注于确定肾脏疾病内外的医疗状况。他们目前的开发计划着重于两种新型疗法的开发:UNI 218或Renazorb(用于治疗慢性肾脏病患者的高磷酸盐血症)和UNI 494(用于治疗急性肾脏损伤)。","exchange":"NASDAQ","nameEN":"Unicycive Therapeutics, Inc.","compareStock":{"symbol":"SPY","name":"标普500ETF"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.13.0","shortVersion":"4.13.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Unicycive Therapeutics, Inc.,UNCY,Unicycive Therapeutics, Inc.股票,Unicycive Therapeutics, Inc.股票老虎,Unicycive Therapeutics, Inc.股票老虎国际,Unicycive Therapeutics, Inc.行情,Unicycive Therapeutics, Inc.股票行情,Unicycive Therapeutics, Inc.股价,Unicycive Therapeutics, Inc.股市,Unicycive Therapeutics, Inc.股票价格,Unicycive Therapeutics, Inc.股票交易,Unicycive Therapeutics, Inc.股票购买,Unicycive Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}